Blackletter
Group
Pharma's entire value chain is becoming digitized with novel and emerging technologies
But investments in innovation are struggling to make a strong business impact
Pharma re-invests 65% of its revenues in innovation - the most of any other industry
But only half of pharma companies feel this re-investment makes a strong impact on revenue
And even less companies see a direct cost reduction from re-investing in innovation
What Pharma Executives Tell Us Behind the Scenes
"We just don't have resources to succeed in digital because those efforts are significant. There are many, many, many points along the journey where we can fail"
How We Position Our Clients for Success
Bridge Core and Digital
Capturing Value from Digital in not Easy
Our clients build strong internal demand for digital, generate Quick Wins, implement value-added pilots and articulate a future reality where digital in part-and-parcel of how Pharma does business and generates competitive advantage
Access New Digital Ecosystems
Compelling Innovation is Hard to Find
Competition for good innovation is fierce - rapidly accessing new ecosystems and being open to deep capabilities and teams from outside Pharma (e.g., voicetech) has served our clients well in creating new markets and differentiated solutions
Accelerate Corporate Change
Science-to-Business Needs to be Faster
Evaluating digital opportunities could take a long time - using our scientific expertise and the lens of an experienced investor, we only expose our clients to vetted, high-grade opportunities that will be in high demand by the Core business
Regain Strategic Control
Rapid Change is Hard to Keep a Pulse On
Making sense of a rapidly-evolving digital ecosystem and getting a sense for where the market is going - our clients are exposed to global insights, teams and competitor moves critical to implementing a digital innovation strategy
William Gibson (founder of cyberpunk)